T1	Participants 145 167	rectal cancer patients
T2	Participants 323 404	rectal carcinoma patients without distant metastasis or peritoneal carcinomatosis
T3	Participants 467 551	51 rectal carcinoma patients without distant metastasis or peritoneal carcinomatosis
